Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-9.
Failed Impurities/Degradation Specifications
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
|---|---|
| Reason | Failed Impurities/Degradation Specifications |
| Risk class | Class III (Class III · low) |
| Status | Ongoing |
| Report date | Oct 14, 2026 |
| Initiated | Sep 25, 2026 |
| Region | NJ, United States |
| Distribution | US Nationwide. |
| Quantity | N/A |
| Code/Lot | Lot # AD96184, Exp Date: 12/31/2026. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0033-2027 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0033-2027)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.